The Premium Business Information Source™

  

 

Genentech, a unit of Roche Holding AG's Roche Holdings, acquired a minority interest in Glycomed for $#.# mil. The transaction was part of a research project to develop carbohydrate-based therapeutic drugs.… Deal Information Credit & Investment Research Market Research News

Roche Holding AG (parent of Genentech Inc) Mergers & Acquisitions Roche Holding AG acquires remaining interest in Genentech Inc (3/26/2009 12:00:00 AM) Genentech Inc intends a stock buyback (4/15/2008 12:00:00 AM) Genentech Inc acquires Tanox Inc (8/2/2007 12:00:00 AM) Genentech Inc acquires Biogen Idec-Biologics Mnfr Fac from Biogen Idec Inc (6/24/2005 12:00:00 AM) Genentech Inc buys back stock (9/28/2004 12:00:00 AM) Genentech Inc intends a stock buyback (9/28/2004 12:00:00 AM) Genentech Inc intends a stock buyback (8/19/2002 12:00:00 AM) Genentech Inc intends a stock buyback (11/8/2001 12:00:00 AM) Genentech Inc acquires Glaxo Wellcome-Cell Culture from GlaxoSmithKline PLC (4/6/2000 12:00:00 AM) Roche Holding AG acquires remaining interest in Genentech Inc (6/16/1999 12:00:00 AM) More.. Glycomed Incorporated Mergers & Acquisitions Ligand Pharmaceuticals Inc acquires Glycomed Inc (5/18/1995 12:00:00 AM) Eli Lilly & Co acquires a minority stake in Glycomed Inc (1/31/1990 12:00:00 AM) More..

Copyright © 2009 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.